{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:39:04Z","timestamp":1782340744397,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bcp.2025.117033","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:49:29Z","timestamp":1749037769000},"page":"117033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["KLF3 aggravates renal fibrosis in chronic kidney disease through transcriptional activation of DDAH2"],"prefix":"10.1016","volume":"239","author":[{"given":"Jing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","article-title":"A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives","volume":"39","author":"Evans","year":"2022","journal-title":"Adv. Ther."},{"issue":"10225","key":"10.1016\/j.bcp.2025.117033_b0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Collaboration","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.117033_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2025.117033_b0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117033_b0025","article-title":"Suppression of LMCD1 ameliorates renal fibrosis by blocking the activation of ERK pathway","volume":"1869","author":"Yu","year":"2022","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bcp.2025.117033_b0030","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.4049\/jimmunol.1101450","article-title":"Impaired B cell development in the absence of Kruppel-like factor 3","volume":"187","author":"Vu","year":"2011","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117033_b0035","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/db12-1745","article-title":"Loss of Kruppel-like factor 3 (KLF3\/BKLF) leads to upregulation of the insulin-sensitizing factor adipolin (FAM132A\/CTRP12\/C1qdc2)","volume":"62","author":"Bell-Anderson","year":"2013","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.bcp.2025.117033_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003612","article-title":"ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in mice","volume":"9","author":"Kelsey","year":"2013","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.bcp.2025.117033_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100078","article-title":"KLF3 transcription activates WNT1 and promotes the growth and metastasis of gastric cancer via activation of the WNT\/beta-catenin signaling pathway","volume":"103","author":"Li","year":"2023","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2025.117033_b0050","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00085.2024","article-title":"KLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle","author":"Fu","year":"2024","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2025.117033_b0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.omtn.2019.12.013","article-title":"N(6)-methyladenosine: a potential breakthrough for human cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bcp.2025.117033_b0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.omtn.2019.11.022","article-title":"Epigenetic regulation of m(6)A modifications in human cancer","volume":"19","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","article-title":"The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12943-020-01233-2","article-title":"Novel insights into the interplay between m(6)A modification and noncoding RNAs in cancer","volume":"19","author":"Yi","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2025.117033_b0075","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/HYPERTENSIONAHA.108.114207","article-title":"Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells","volume":"52","author":"Sakurada","year":"2008","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2025.117033_b0080","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/2211-5463.12949","article-title":"Renal asymmetric dimethylarginine inhibits fibrosis","volume":"10","author":"Wu","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"11","key":"10.1016\/j.bcp.2025.117033_b0085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bcp.2025.117033_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Martinez-Klimova","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0095","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10565-024-09929-7","article-title":"S100A2 activation promotes interstitial fibrosis in kidneys by FoxO1-mediated epithelial-mesenchymal transition","volume":"40","author":"Yang","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117033_b0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41419-024-06780-w","article-title":"HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12967-023-04376-0","article-title":"UCP1 alleviates renal interstitial fibrosis progression through oxidative stress pathway mediated by SIRT3 protein stability","volume":"21","author":"Xiong","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0110","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/s41467-023-37450-8","article-title":"Neuraminidase 1 promotes renal fibrosis development in male mice","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117033_b0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/tpj.16996","article-title":"Evolution and post-transcriptional regulation insights of m(6)A writers, erasers, and readers in plant epitranscriptome","volume":"120","author":"Zhang","year":"2024","journal-title":"Plant J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117033_b0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","article-title":"N6-methyladenosine methyltransferases: functions, regulation, and clinical potential","volume":"14","author":"Huang","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117033_b0125","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.7150\/ijbs.45231","article-title":"Function and evolution of RNA N6-methyladenosine modification","volume":"16","author":"Zhu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117033_b0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/15476286.2019.1620060","article-title":"N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction","volume":"16","author":"Chen","year":"2019","journal-title":"RNA Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117033_b0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m(6)A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2025.117033_b0140","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1080\/21655979.2022.2051785","article-title":"Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Kruppel-like factor 3 (KLF3) promotes osteosarcoma progression","volume":"13","author":"Shan","year":"2022","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.bcp.2025.117033_b0145","first-page":"2475","article-title":"KLF3 promotes colorectal cancer growth by activating WNT1","volume":"16","author":"Shen","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.bcp.2025.117033_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101320","article-title":"KLF3 mediates epidermal differentiation through the epigenomic writer CBP","volume":"23","author":"Jones","year":"2020","journal-title":"iScience"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225002989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T06:57:35Z","timestamp":1752649055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225002989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S0006295225002989"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117033","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLF3 aggravates renal fibrosis in chronic kidney disease through transcriptional activation of DDAH2","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117033"}}